Evidence map›Paper›PMID 33211144›Full record

ArticleEuropean radiology2021

Tumor contour irregularity on preoperative imaging: a practical and useful prognostic parameter for papillary renal cell carcinoma.

Chenchen Dai, Jiaqi Huang, Yaohui Li, Sihong Zhang, Qinxuan Tan, Jun Hou, Qiying Tang, Xiaoyi Hu, Jianming Guo, Mengsu Zeng and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in European radiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Chenchen Dai *Department of Radiology, Zhongshan Hospital, Fudan University, Shanghai Medical Imaging Institute, No180, Fenglin Road, Xuhui District, Shanghai, China.
Jiaqi Huang *Department of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China.
Yaohui LiDepartment of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China.
Sihong ZhangDepartment of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China.
Qinxuan TanDepartment of Radiology, Zhongshan Hospital, Fudan University, Shanghai Medical Imaging Institute, No180, Fenglin Road, Xuhui District, Shanghai, China.
Jun HouDepartment of Pathology, Zhongshan Hospital, Fudan University, No180, Fenglin Road, Xuhui District, Shanghai, China.
Qiying TangDepartment of Radiology, Xiamen Branch, Zhongshan Hospital, Fudan University, No 668, Jinhu Road, Huli District, Xiamen, Fujian province, China.
Xiaoyi HuDepartment of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China.
Jianming GuoDepartment of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China.
Mengsu ZengDepartment of Radiology, Zhongshan Hospital, Fudan University, Shanghai Medical Imaging Institute, No180, Fenglin Road, Xuhui District, Shanghai, China.
Hang WangDepartment of Urology, Zhongshan Hospital, Fudan University, No180, Fengling Road, Xuhui District, Shanghai, China. wang.hang@zs-hospital.sh.cn.
Jianjun ZhouDepartment of Radiology, Zhongshan Hospital, Fudan University, Shanghai Medical Imaging Institute, No180, Fenglin Road, Xuhui District, Shanghai, China. zhoujianjunzs@126.com.ORCID http://orcid.org/0000-0003-4175-0513
Sun Yat-sen University · CNFudan University · CNShanghai Medical College of Fudan University · CN

Funding

Fujian Provincial Department of Science and Technology 2019D025Medical and Health Key Project of Xiamen 3502Z20199716Scientific Research Cultivation and Medical Innovation Project of Fujian Province 2019CXB33Shanghai Municipal Health Commission 2019SY073
6 · The paper itself

Abstract

objectivesTo illustrate tumor contour irregularity on preoperative imaging with a practical method and further determine its value in predicting disease-free survival (DFS) in patients with pRCC (papillary renal cell carcinoma).

methodsWe performed a retrospective single-institution review of 267 Chinese pRCC patients between March 2009 and May 2019. Contour irregularity on cross-section was classified into smooth but distorted margin, unsmooth and sharply nodular margin, and blurred margin. Then, the ratio of the cross-section numbers of irregularity and the total tumor was defined as the contour irregular degree (CID). Cox regression and Kaplan-Meier analysis were performed to analyze the impact of CID on DFS. Then, the prognostic performance of CID was compared with pRCC risk stratification published by Leibovich et al.

resultsThe median follow-up was 45 months (IQR: 23-69), in which 27 (10%) patients had metastasis or recurrence. Observed DFS rates were 95%, 90%, and 88% at 1, 3, and 5 years. The CID was an independent prognostic factor of DFS (HR = 1.048, 95% CI = 1.029-1.068, p < 0.001). The Kaplan-Meier plot showed that high-risk patients (CID ≥ 50%) tended to have a significantly shorter DFS (p < 0.001). The CID and Leibovich's pRCC model for DFS prediction had a C-index of 0.934 (95% CI = 0.907-0.961) and 0.833 (95% CI = 0.739-0.927) respectively.

conclusionsWith our standard and practical method, the CID can be a reliable imaging marker for DFS prediction in patients with pRCC. KEY POINTS: • The updated contour irregularity was an independent parameter for predicting disease-free survival in patients with pRCC. • High-risk pRCC patients (contour irregular degree ≥ 50%) tended to have a shorter disease-free survival. • Tumor contour irregularity in pRCC risk stratification outperformed Leibovich's model from our cohort.

Indexed as

Carcinoma, Renal CellKidney NeoplasmsHumansNeoplasm Recurrence, LocalPrognosisRetrospective StudiesPapillary renal cell carcinomaPrognosisRisk

Identifiers

PMID33211144
OpenAlexW3103326599

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.